Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
1.040
-0.050 (-4.59%)
At close: Feb 21, 2025, 4:00 PM
1.080
+0.040 (3.84%)
After-hours: Feb 21, 2025, 6:24 PM EST
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.51M in the quarter ending September 30, 2024, with 22.07% growth. This brings the company's revenue in the last twelve months to $8.88M, down -9.49% year-over-year. In the year 2023, Milestone Scientific had annual revenue of $9.83M with 11.60% growth.
Revenue (ttm)
$8.88M
Revenue Growth
-9.49%
P/S Ratio
9.21
Revenue / Employee
$522,177
Employees
17
Market Cap
81.01M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
Dec 31, 2019 | 8.37M | -1.25M | -12.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
MLSS News
- 18 days ago - Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC - GlobeNewsWire
- 4 weeks ago - Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon - GlobeNewsWire
- 2 months ago - Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024 - GlobeNewsWire
- 3 months ago - Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System - GlobeNewsWire
- 3 months ago - Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 - GlobeNewsWire
- 3 months ago - Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO - GlobeNewsWire
- 3 months ago - Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call - GlobeNewsWire